Rule/Regulation Violated:
R9-10-120. Opioid Prescribing and Treatment
F. For a health care institution where opioids are administered as part of treatment or where a patient is provided assistance in the self-administration of medication for a prescribed opioid, including a health care institution in which an opioid may be prescribed or ordered as part of treatment, a medical director, a manager as defined in R9-10-801, or a provider, as applicable to the health care institution, shall:
4. Except as provided in subsection (H), ensure that an individual authorized by policies and procedures to administer an opioid in treating a patient or to provide assistance in the self-administration of medication for a prescribed opioid:
a. Before administering an opioid or providing assistance in the self-administration of medication for a prescribed opioid in compliance with an order as part of the treatment for a patient, identifies the patient's need for the opioid;
b. Monitors the patient's response to the opioid; and
c. Documents in the patient's medical record:
i. An identification of the patient ' s need for the opioid before the opioid was administered or assistance in the self-administration of medication for a prescribed opioid was provided, and
ii. The effect of the opioid administered or for which assistance in the self-administration of medication for a prescribed opioid was provided.
Evidence/Findings:
Based on observation, record review, documentation review, and interview, for one resident reviewed receiving opioid medication without an active malignancy or an end of life condition, the manager failed to ensure an individual authorized to administer opioids documented in the resident's medical record an identification of the resident's need for the opioid before the opioid was administered and the monitoring of the effect of the opioid administered. The deficient practice posed a risk to a resident if a resident's pain was not identified, monitored, and documented, as required.
Findings include:
1. In observation, R2 had Tramadol 50mg medication, (a schedule IV controlled substance), take one tablet three times daily. The package indicated 90 tablets were dispensed on June 21, 2023, with 80 tablets remaining.
2. In record review, R2's medical record (received personal care and medication administration services) included documentation R2 received the opioid medication as ordered; however, the record did not include documentation of an identification of the resident's need for the opioid, and the monitoring of the effect of the opioid administered. R2's medical record did not include documentation R2 had an active malignancy or an end of life condition.
3. In documentation review, a facility policy, titled "... Pain Management and Opioid Medications, on page 289, documented, Opioid Administration... must include 1. Identification and documentation of the resident's pain level prior to medication using the pain scale... ii. Monitoring resident's response to medicaiton. iii. Documenting the effectiveness of medication forty-five minutes after administration in resident's record. Document on the MAR the resident's need, monitoring, and response to the medication... The name of the staff member responsible for administering/assisting the resident with the opioid medication... The resident's level of pain prior to administering the medication... How the ... level of pain was assessed... How the resident's response was monitored including the time and person(s) responsible for monitoring... The resulting effect of the medication on the resident."
4. During an interview, E1 and E2 reported R2 received an opioid medication, and acknowledged the facility did not identify and document the residents' need for the opioid before the opioid was administered, and monitor and document the effect of the opioid administered, according to the facility's policies and procedures.
Summary:
No deficiencies were found during the on-site compliance inspection and investigation of complaint 00141310 conducted on August 28, 2025.